• As Koronis concludes the proof-of-concept for VDA in HIV, the next step is a development partnership to fund additional late-stage clinical development. In addition, Koronis is seeking a development partner for the preclinical HCV program. An interesting company to watch – a likely licensing opportunity down the line.